TP53 Apoptosis Effector (PERP) (Middle Region) Peptid

Details zu Produkt Nr. ABIN981592, Anbieter: Anmelden zum Anzeigen
Proteinname
  • KCP1
  • KRTCAP1
  • PIGPC1
  • RP3-496H19.1
  • THW
  • dJ496H19.1
  • 1110017A08Rik
  • kcp1
  • krtcap1
  • pigpc1
  • thw
  • fk24g11
  • wu:fk24g11
  • PERP
  • PERP, TP53 apoptosis effector
  • PERP, TP53 apoptosis effector S homeolog
  • PERP
  • Perp
  • perp.S
  • perp
Protein Region
Middle Region
Spezies
Human
3
1
1
1
1
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Optionen
Hersteller
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Geblockter Antikörper anti-PERP Antikörper (TP53 Apoptosis Effector) (Middle Region) (ABIN2783850)
Produktmerkmale This is a synthetic peptide designed for use in combination with anti-PERP antibody (Catalog #: ARP49688_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Reinigung Purified
Proteinname
Hintergrund PERP is a component of intercellular desmosome junctions. PERP plays a role in stratified epithelial integrity and cell-cell adhesion by promoting desmosome assembly. PERP also plays a role as an effector in the TP53-dependent apoptotic pathway.

Alias Symbols: KCP1, KRTCAP1, PIGPC1, RP3-496H19.1, THW, dJ496H19.1

Protein Size: 193
Molekulargewicht 21 kDa
Gen-ID 64065
NCBI Accession NM_022121, NP_071404
UniProt Q96FX8
Applikations-hinweise Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Lyophilized
Rekonstitution Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration 1 mg/mL
Buffer Final peptide concentration is 1 mg/mL in PBS.
Handhabung Avoid repeated freeze-thaw cycles.
Lagerung -20 °C
Informationen zur Lagerung For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.